Franklin Resources
OLMA icon

Franklin Resources’s Olema Pharmaceuticals OLMA Stock Holding History

Franklin Resources’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.4M Buy
2,349,586
+1,130,629
+93% +$15.1M 0.01% 874
2026
Q1 		$18.2M Sell
1,218,957
-1,257,708
-51% -$28M ﹤0.01% 1025
2025
Q4 		$61.9M Sell
2,476,665
-535,304
-18% -$9.53M 0.02% 576
2025
Q3 		$29.5M Hold
3,011,969
– – 0.01% 830
2025
Q2 		$12.8M Hold
3,011,969
– – ﹤0.01% 1052
2025
Q1 		$11.3M Buy
3,011,969
+2,738,263
+1,000% +$13.8M ﹤0.01% 1065
2024
Q4 		$1.6M Buy
273,706
+258,625
+1,715% +$2.58M ﹤0.01% 1806
2024
Q3 		$177K Hold
15,081
– – ﹤0.01% 2664
2024
Q2 		$163K Buy
15,081
+2,210
+17% +$24K ﹤0.01% 2598
2024
Q1 		$146K Hold
12,871
– – ﹤0.01% 2656
2023
Q4 		$181K Hold
12,871
– – ﹤0.01% 2371
2023
Q3 		$159K Buy
+12,871
New +$131K ﹤0.01% 2380
2021
Q3 		– Sell
-412,205
Closed -$11.5M – 2486
2021
Q2 		$11.5M Buy
412,205
+42,200
+11% +$1.2M ﹤0.01% 989
2021
Q1 		$12.3M Hold
370,005
– – 0.01% 931
2020
Q4 		$17.8M Buy
+370,005
New +$17.3M 0.01% 837

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Franklin Resources's OLMA Position: Q2 2026 in Review

Franklin Resources increased its Olema Pharmaceuticals (OLMA) stake by 93% in Q2 2026, buying an estimated $15.1M and bringing the position to 2,349,586 shares worth $29.4M. The position accounts for 0.01% of the portfolio, ranked #874.

Franklin Resources first reported a position in OLMA in Q4 2020 and has held it in 15 quarters since. The position peaked at $61.9M in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Franklin Resources held 2,349,586 shares of Olema Pharmaceuticals worth $29.4M as of Q2 2026.
  • Franklin Resources bought 1,130,629 Olema Pharmaceuticals shares in Q2 2026, an estimated $15.1M.
  • Olema Pharmaceuticals made up 0.01% of Franklin Resources's portfolio in Q2 2026, its #874 holding.
  • Franklin Resources first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 15 quarters since.
  • Franklin Resources's Olema Pharmaceuticals position peaked at $61.9M in Q4 2025.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.